Elanco Animal Health Inc (ELAN): Gross Profit
$2.59B
Year ended 2025-12-31
$2.78B
Trailing 12 months to 2026-06-30
+1.3%
3-year compound annual growth
+10.1%
5-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.59B | +6.4% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $2.44B | -2.0% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $2.49B | -0.5% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $2.50B | -5.1% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $2.63B | +63.9% | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | $1.61B | +0.3% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $1.60B | +7.2% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $1.49B | +7.0% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $1.40B | -7.3% | 2020-02-28, From 2017-01-01 |
| 2016-12-31 | $1.50B | n/a | 2019-02-20, From 2016-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $2.59B | +6.4% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $1.49B | -3.1% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $4.67B | +45.3% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $3.04B | +56.4% |
| Organon & Co. (OGN) | 2025-12-31 | $3.31B | -10.8% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $2.50B | +10.1% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $2.80B | +9.0% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $1.11B | +9.1% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $6.80B | +4.0% |
Compare ELAN, PRGO, ONC, ALNY side by side · Screen every company in Pharmaceutical Preparations ↗